Literature DB >> 25387047

Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Luna Xu1, Sarah Mrejen, Jesse J Jung, Roberto Gallego-Pinazo, Desmond Thompson, Marcela Marsiglia, K Bailey Freund.   

Abstract

PURPOSE: To examine factors associated with the apparent growth of geographic atrophy (GA) in a consecutive series of eyes with treatment-naive neovascular age-related macular degeneration receiving intravitreal anti-vascular endothelial growth factor therapy on a treat-and-extend regimen.
METHODS: This was a retrospective cohort study. Two independent graders identified areas of GA using near-infrared reflectance imaging and spectral domain optical coherence tomography (SD-OCT). Neovascular lesion subtypes were classified based on fluorescein angiography (FA) as occult choroidal neovascularization, classic choroidal neovascularization, retinal angiomatous proliferation, or mixed choroidal neovascularization, and by the anatomical classification system which utilizes FA and SD-OCT as Types 1 (sub-retinal pigment epithelium), 2 (subretinal), 3 (intraretinal), or mixed neovascularization.
RESULTS: Ninety-one patients (94 eyes) fit the inclusion criteria, of which 52 eyes (55.3%) experienced apparent GA growth. The odds of developing apparent GA were significantly lower in Type 1 neovascularization compared to the other lesion types (P < 0.001). Using both FA and SD-OCT to classify neovascular age-related macular degeneration significantly improves the goodness of fit in the correlation between apparent GA growth and baseline neovascular lesion type (P < 0.001).
CONCLUSION: Treatment-naive neovascular age-related macular degeneration eyes with Type 1 neovascularization at baseline were less likely to develop GA than eyes with other types. The correlation between apparent GA growth and subtype of neovascularization is stronger when lesions are classified with an anatomic grading that utilizes both FA and SD-OCT.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25387047     DOI: 10.1097/IAE.0000000000000374

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  36 in total

1.  [OCT angiography for exudative age-related macular degeneration : Initial experiences].

Authors:  A Lommatzsch; M-L Farecki; B Book; B Heimes; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2016-01       Impact factor: 1.059

2.  Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration.

Authors:  Cheolmin Yun; Jaeryung Oh; Jaemoon Ahn; Soon-Young Hwang; Boram Lee; Seong-Woo Kim; Kuhl Huh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-19       Impact factor: 3.117

3.  Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Authors:  Ebenezer Daniel; James Shaffer; Gui-shuang Ying; Juan E Grunwald; Daniel F Martin; Glenn J Jaffe; Maureen G Maguire
Journal:  Ophthalmology       Date:  2015-12-08       Impact factor: 12.079

4.  Evolution of Geographic Atrophy in Participants Treated with Ranibizumab for Neovascular Age-related Macular Degeneration.

Authors:  Alisa T Thavikulwat; Naima Jacobs-El; Jane S Kim; Elvira Agrón; Jesia Hasan; Catherine B Meyerle; David Valent; Catherine A Cukras; Henry E Wiley; Wai T Wong; Emily Y Chew
Journal:  Ophthalmol Retina       Date:  2017 Jan-Feb

5.  [Long-term results in neovascular age-related macular degeneration : Changes in visual acuity and geographic atrophy during long-standing anti-VEGF therapy].

Authors:  V Thalgott; N Feucht; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

6.  VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO ATROPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Authors:  Emma C Zanzottera; Thomas Ach; Carrie Huisingh; Jeffrey D Messinger; K Bailey Freund; Christine A Curcio
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

Review 7.  A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration.

Authors:  U Schmidt-Erfurth; S Klimscha; S M Waldstein; H Bogunović
Journal:  Eye (Lond)       Date:  2016-11-25       Impact factor: 3.775

Review 8.  Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review.

Authors:  Patrick Kaszubski; Tal Ben Ami; Celine Saade; R Theodore Smith
Journal:  Ophthalmic Res       Date:  2016-02-13       Impact factor: 2.892

9.  Results of patients with neovascular age-related macular degeneration managed by a treat-extend-stop protocol without recurrence.

Authors:  Sean D Adrean; Siyang Chaili; Ash Pirouz; Scott Grant
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-12       Impact factor: 3.117

Review 10.  Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents.

Authors:  M Gemenetzi; A J Lotery; P J Patel
Journal:  Eye (Lond)       Date:  2016-10-07       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.